U.S. Global Investors (USGI)’s Pfizer PFE Stock Holding History

U.S. Global Investors (USGI)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-10,540	Closed	-$336K	–	173
2017 Q2	$336K	Sell	10,540 -9,486	-47%	-$299K	0.12%	116
2017 Q1	$650K	Buy	20,026 +2,846	+17%	+$89.7K	0.31%	76
2016 Q4	$529K	Buy	+17,180	New	+$524K	0.22%	90
2016 Q1	–	Sell	-11,594	Closed	-$355K	–	237
2015 Q4	$355K	Buy	11,594 +4,743	+69%	+$149K	0.19%	130
2015 Q3	$204K	Hold	6,851	–	–	0.11%	157
2015 Q2	$218K	Hold	6,851	–	–	0.08%	207
2015 Q1	$226K	Hold	6,851	–	–	0.06%	235
2014 Q4	$202K	Hold	6,851	–	–	0.05%	230
2014 Q3	$192K	Hold	6,851	–	–	0.05%	209
2014 Q2	$193K	Hold	6,851	–	–	0.04%	218
2014 Q1	$209K	Hold	6,851	–	–	0.03%	242
2013 Q4	$199K	Hold	6,851	–	–	0.04%	255
2013 Q3	$187K	Hold	6,851	–	–	0.03%	237
2013 Q2	$182K	Buy	+6,851	New	+$189K	0.03%	236

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

U.S. Global Investors (USGI)'s PFE Position: Q3 2017 in Review

U.S. Global Investors (USGI) sold out of Pfizer (PFE) in Q3 2017, closing a stake of 10,540 shares — an estimated $336K sold.

U.S. Global Investors (USGI) first reported a position in PFE in Q2 2013 and held it in 14 quarters. The position peaked at $650K in Q1 2017. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

U.S. Global Investors (USGI) reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
U.S. Global Investors (USGI) sold 10,540 Pfizer shares in Q3 2017, an estimated $336K.
U.S. Global Investors (USGI) first reported a position in Pfizer in Q2 2013 and held it in 14 quarters.
U.S. Global Investors (USGI)'s Pfizer position peaked at $650K in Q1 2017.
2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on U.S. Global Investors (USGI)'s 13F filing for Q3 2017, filed 13 Nov 2017.